Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.

Oncogene - 24 Feb 2011

Hill V K, Underhill-Day N, Krex D, Robel K, Sangan C B, Summersgill H R, Morris M, Gentle D, Chalmers A D, Maher E R, Latif F

Abstract excerpt

We have recently described the N-terminal RAS association domain family of genes, RASSF7-10. Previously, we cloned the N-terminal RASSF10 gene and demonstrated frequent methylation of the associated 5'-CpG island in acute lymphoblastic leukemia. To characterize RASSF10 gene expression, we demonst...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Gene Silencing
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to In Situ Hybridization

Share to Isocitrate Dehydrogenase

Share to Proportional Hazards Models

Share to Xenopus

Source

Identifiers

PMID: 20956940
DOI: 10.1038/onc.2010.471

Genes

RASSF10
RASSF7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20956940-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.PMID 20956940Read ↗

Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for gliomaSemantic proximity Read ↗

Developmentally regulated signaling pathways in glioma invasionSemantic proximity Read ↗

The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemiasSemantic proximity Read ↗

Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem gliomaSemantic proximity Read ↗

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastomaSemantic proximity Read ↗

Ubiquitous aberrant RASSF1A promoter methylation in childhood neoplasia.Semantic proximity Read ↗

MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS.Semantic proximity Read ↗

RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.Semantic proximity Read ↗

Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human NeuroblastomaSemantic proximity Read ↗

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignanciesSemantic proximity Read ↗

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.Semantic proximity Read ↗

Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.